Samir Mehta, MD
Orthopaedic Surgery · Philadelphia, PANPI 1003851817
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $2,938,992 of the $3,646,149 with a category attached, or 80.6%. Smith+Nephew accounts for 69.5% of it on its own, with 40 other manufacturers making up the rest. 2025 is the largest year on record at $753,812, 2.7 times the $278,597 reported in 2019. Among orthopaedic surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 729 payments — averaging $5001.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$2.5M
- Depuy Synthes Products, Inc.$506K
- Stryker$178K
- Globus Medical$107K
- Medical Device Business Services, Inc.$79K
- Curvafix, Inc.$75K
- plus $169K from 35 others
Across 1 payment — averaging $5399.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GE HealthCare$5K
Across 5 payments — averaging $6921.15 each. An ownership or investment interest held by the physician or an immediate family member.
- Curvafix, Inc.$35K
- Trice Medical, Inc.$0
What the payments were for
- Royalty or licence$2,938,99281%
- Consulting fees$351,50410%
- Speaking & faculty fees$249,0537%
- Travel & lodging$92,5293%
- Food & beverage$14,0710%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVOS$2,691,815
- EXPert Nail$402,989
- EVOS MINI$276,338
- EX NAILS$124,983
- TRIGEN InterTAN$92,182
- CurvaFix IM Implant$74,376
- Other Infix$70,786
- AXSOS$54,750
- VA-LCP$53,541
- GAMMA$52,913
- HOFFMANN$46,800
- TROCH NAIL$43,736
- PRO$38,599
- VARIAX$38,569
- TRIGEN$38,355
- EXTERNAL FIXATION$29,956
- T2 ALPHA$29,710
- REDAPT$29,653
- T2$29,645
- IM NAILS$29,161
How this compares
$3,646,149 in reported general payments places this provider in the 95th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other orthopaedic surgery in Philadelphia
- John FenlinPhiladelphia$5.9M
- Alexander VaccaroPhiladelphia$4.5M
- Joseph AbboudPhiladelphia$3.9M
- Surena NamdariPhiladelphia$1.8M
- Neil ShethPhiladelphia$522K
- Amrit KhalsaPhiladelphia$475K
- Vahid EntezariPhiladelphia$393K
- Charles NelsonPhiladelphia$345K
- David GlaserPhiladelphia$176K
- Anthony NduPhiladelphia$173K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.